Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 22 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
VH Pharma from Beveren-Kruibeke-Zwijndrecht, company number BE0788292373, closed financial year 2025 with a result of € 38,454 after tax. For that financial year VH Pharma recorded a gross margin of € 99,456 and equity of € 236,430. Compared with financial year 2024, the result moved from € 154,962 to € 38,454. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 236,430
▲ 19% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 38,454
▼ 75% vs 2024
Profit after tax over the fiscal year.
€ 8,961
▲ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 235,430.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 1,338
▼ 35% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 593,756
▼ 19% vs 2024
€ 41,297 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.
€ 7,140
▲ 211% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,034
▼ 85% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 30,129 | € 101,616 | € 113,138 | € 99,456 | ▼ 12% |
| Profit after taxes | € 21,209 | € 20,804 | € 154,962 | € 38,454 | ▼ 75% |
| Equity | € 22,209 | € 43,013 | € 197,975 | € 236,430 | ▲ 19% |
| Total debts | € 517,557 | € 847,891 | € 781,386 | € 642,853 | ▼ 18% |
| Cash | € 21,799 | € 14,299 | € 6,870 | € 8,961 | ▲ 30% |
| Land & buildings | - | € 358,533 | € 350,016 | € 341,500 | ▼ 2% |
| Retained profit | € 21,209 | € 42,013 | € 196,975 | € 235,430 | ▲ 20% |
| Bank debt | € 251,116 | € 598,083 | € 733,858 | € 593,756 | ▼ 19% |
| Balance sheet total | € 539,765 | € 890,904 | € 979,362 | € 879,283 | ▼ 10% |
Key figures of VH Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VH Pharma?
What happened at VH Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 38,454 (▼ 75% vs 2024). Source: NBB ↗
- New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
- Start of the company according to the CBE. KBO
- Elien Irène Van Hove became a director. NBB
In short
From € 21,209 profit in 2022 to € 38,454 profit in 2025.
Paid € 44,256 in corporate taxes since 2022.
Best year ever: 2024, with € 154,962 profit.
A new publication or filing at VH Pharma? We notify you, reason included.
Follow VH PharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind VH Pharma is Elien Irène Van Hove. It owns 100% of Mentover itself.
Directors
According to the 2025 annual accounts
since 2022
Establishments
Establishment units
Physical locations of this company
Neerbroek 44
2070 Beveren-Kruibeke-Zwijndrecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
COMBELL-AS, BE
Website info
Features
Security
Details
- Company number
- 0788.292.373
- VAT number
- BE 0788.292.373
- Registered office
- Neerbroek 44, 2070 Beveren-Kruibeke-Zwijndrecht
- Names & denominations
- VH Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 July 2022
- Peppol
- Active · Active since 5 Jun 2024
- Contact
- z-pharma.be
- Activities · NACE
Activiteiten van holdings
Holdings